Neurocrine Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	12,873	14,197	13,568	13,005	11,526	8,083
Market Cap Growth	42.33%	4.64%	4.33%	12.83%	42.60%	-9.81%
Enterprise Value	11,919	13,132	12,947	12,231	10,630	7,812
Last Close Price	127.99	141.83	136.50	131.76	119.44	85.17
PE Ratio	27.42	30.37	41.49	53.34	76.56	92.58
Forward PE	13.66	15.87	18.15	21.34	22.53	24.55
PEG Ratio	0.41	0.75	0.31	0.65	0.66	0.37
PS Ratio	4.52	4.96	5.76	6.89	7.74	7.13
PB Ratio	3.94	4.36	5.24	5.83	6.75	5.88
P/TBV Ratio	4.03	4.47	5.47	5.96	6.92	6.07
P/FCF Ratio	17.27	18.96	24.35	35.96	35.70	34.67
P/OCF Ratio	16.52	18.14	22.79	33.35	33.96	31.51
EV/Sales Ratio	4.17	4.59	5.50	6.48	7.14	6.89
EV/EBITDA Ratio	17.88	20.23	21.67	44.94	40.17	68.89
EV/EBIT Ratio	18.73	21.21	22.69	48.75	42.69	76.21
EV/FCF Ratio	15.92	17.54	23.24	33.83	32.92	33.51
Debt / Equity Ratio	0.13	0.13	0.18	0.12	0.05	0.32
Debt / EBITDA Ratio	0.64	0.64	0.76	1.57	0.99	3.88
Debt / FCF Ratio	0.56	0.56	0.82	1.19	0.81	1.89
Net Debt / Equity Ratio	-0.33	-0.33	-0.24	-0.27	-0.42	-0.20
Net Debt / EBITDA Ratio	-1.64	-1.64	-1.04	-2.22	-2.74	-2.39
Net Debt / FCF Ratio	-1.42	-1.42	-1.11	-1.67	-2.25	-1.16
Asset Turnover	0.69	0.69	0.68	0.67	0.67	0.60
Inventory Turnover	0.82	0.82	0.71	1.08	0.71	0.49
Quick Ratio	2.92	2.92	3.06	2.25	2.49	3.65
Current Ratio	3.39	3.39	3.40	2.45	2.70	3.96
Return on Equity (ROE)	16.38%	16.38%	14.16%	12.68%	10.03%	7.17%
Return on Assets (ROA)	10.06%	10.06%	11.50%	6.71%	8.10%	4.76%
Return on Invested Capital (ROIC)	18.04%	18.04%	20.28%	13.46%	16.60%	9.53%
Return on Capital Employed (ROCE)	17.44%	17.44%	19.65%	11.33%	13.62%	6.07%
Earnings Yield	3.70%	3.29%	2.41%	1.87%	1.31%	1.08%
FCF Yield	5.79%	5.27%	4.11%	2.78%	2.80%	2.88%
Buyback Yield / Dilution	1.16%	1.16%	-2.67%	-2.12%	-1.02%	-0.10%
Total Shareholder Return	1.16%	1.16%	-2.67%	-2.12%	-1.02%	-0.10%

Updated Feb 11, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q